Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Hip Fractures, Hip Osteoarthritis
4.2.2 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of the Treatment
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Primary Hip Reconstruction Devices
5.1.2 Partial Hip Reconstruction Devices
5.1.3 Hip Resurfacing Devices
5.1.4 Other
5.2 Bt End-User
5.2.1 Hospitals
5.2.2 Orthopedic Clinics
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zimmer Biomet
6.1.2 Johnson & Johnson
6.1.3 Stryker
6.1.4 Smith & Nephew
6.1.5 B. Braun Melsungen AG
6.1.6 Waldemar Link GmbH & Co. KG
6.1.7 Surgival
6.1.8 Exactech, Inc.
6.1.9 Limacorporate S.p.a.
6.1.10 Microport


7 MARKET OPPORTUNITIES AND FUTURE TRENDS